Inventor · disambiguated record
Philippe Leboulch
Also filed as: LEBOULCH PHILIPPE · LEBOULCH PHILIPPE LOUIS
20 granted patents·12 pending applications·359 citations·filing 1993–2020
95Inventor score
Files withGENETIX PHARMACEUTICALS INC9BLUEBIRD BIO INC6MASSACHUSETTS INST TECHNOLOGY4KOBAYASHI NAOYA2LEBOULCH PHILIPPE2
Top patents by PatentIndex Score
32 records- 0195US7901671B2Therapeutic retroviral vectors for gene therapyBLUEBIRD BIO INC·Filed 2005·Granted Mar 8, 2011·41 cites·17 claims
- 0293US9068199B2Therapeutic retroviral vectors for gene therapyLEBOULCH PHILIPPE·Filed 2011·Granted Jun 30, 2015·40 cites·18 claims
- 0392US6645763B2Immortalized bone marrow mesenchymal stem cellFiled 2001·Granted Nov 11, 2003·34 cites·1 claims
- 0490US10105451B2Therapeutic retroviral vectors for gene therapyBLUEBIRD BIO INC·Filed 2015·Granted Oct 23, 2018·4 cites·11 claims
- 0588US8034620B2Lentiviral packaging cells and uses thereforBLUEBIRD BIO INC·Filed 2007·Granted Oct 11, 2011·4 cites·14 claims
- 0687US7311907B2Lentiviral packaging cellsGENETIX PHARMACEUTICALS INC·Filed 2005·Granted Dec 25, 2007·6 cites·16 claims
- 0785US6955919B2Lentiviral packaging cells and uses thereforGENETIX PHARMACEUTICALS INC·Filed 2002·Granted Oct 18, 2005·11 cites·10 claims
- 0885US5928914AMethods and compositions for transforming cellsEINSTEIN COLL MED·Filed 1996·Granted Jul 27, 1999·108 cites·24 claims
- 0983US6365150B1Lentiviral packaging cellsGENETIX PHARMACEUTICALS INC·Filed 1999·Granted Apr 2, 2002·44 cites·27 claims
- 1081US10632212B2Therapeutic retroviral vectors for gene therapyBLUEBIRD BIO INC·Filed 2018·Granted Apr 28, 2020·1 cites·17 claims
- 1173US7521234B2Mammalian immortalized liver cellKOBAYASHI NAOYA·Filed 2002·Granted Apr 21, 2009·3 cites·14 claims
- 1272US7033744B2Method for proliferating a liver cell, a liver cell obtained thereby, and use thereofKOBAYASHI NAOYA·Filed 2002·Granted Apr 25, 2006·7 cites·22 claims
- 1371US11701435B2Therapeutic retroviral vectors for gene therapyBLUEBIRD BIO INC·Filed 2020·Granted Jul 18, 2023·0 cites·20 claims
- 1470US5861488ACompositions and methods for treating sickle cell diseaseMASSACHUSETTS INST TECHNOLOGY·Filed 1997·Granted Jan 19, 1999·26 cites·11 claims
- 1565US9623015B2Combination of an anti-cancer agent such as a tyrosinekinase inhibitor and a STAT5 antagonist, preferably a thiazolidinedione, for eliminating hematologic cancer stem cells in vivo and for preventing hematologic cancer relapseCOMMISSARIAT À L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (CEA)·Filed 2013·Granted Apr 18, 2017·1 cites·28 claims
- 1661US6051402ACompositions and methods for treating sickle cell diseaseMASSACHUSETTS INST TECHNOLOGY·Filed 1999·Granted Apr 18, 2000·15 cites·20 claims
- 1760US2007072816A1Methods for inhibiting angiogenesisGENETIX PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 1856US9783822B2Gene therapy methodsNEGRE OLIVER·Filed 2011·Granted Oct 10, 2017·1 cites·12 claims
- 1956US2011274669A1Therapeutic retroviral vectors for gene therapyLEBOULCH PHILIPPE·Filed 2010·Application pending·0 cites
- 2056US2004241141A1Method of treating arthritis using lentiviral vectors in gene therapyGENETIX PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 2155US2004062751A1Methods for inhibiting angiogenesisGENETIX PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 2253US2005158712A1Methods for purifying viral particles for gene therapyGENETIX PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 2352US2007190030A1Method of treating arthritis using lentiviral vectors in gene therapyGENETIX PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 2449US10280435B2Gene therapy methodsBLUEBIRD BIO INC·Filed 2017·Granted May 7, 2019·0 cites·16 claims
- 2545US6534314B1Methods and compositions for transforming cellsMASSACHUSETTS INST TECHNOLOGY·Filed 1999·Granted Mar 18, 2003·6 cites·16 claims
- 2645US2003039636A1Novel self-inactivating (SIN) lentiviral vectorsGENETIX PHARMACEUTICALS INC·Filed 2002·Application pending·0 cites
- 2744US2002013261A1Methods and compositions for promoting angiogenesis using polyethylene glycol (PEG) polymersFiled 2001·Application pending·0 cites
- 2844US2002034501A1Methods and compositions for promoting angiogenesis using monocytesFiled 2001·Application pending·0 cites
- 2943US2014199279A1Methods for enhancing the delivery of gene-transduced cellsDOWN JULIAN DAVID·Filed 2011·Application pending·0 cites
- 3040US2020208112A1Method of Selecting Genetically Modified Hematopoietic Stem CellsCOMMISSARIAT A IENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES·Filed 2018·Application pending·0 cites
- 3139US2007264243A1Reversibly immortalized hepatocytes and methods of useFOX IRA J·Filed 2007·Application pending·0 cites
- 3237US5631162ARetroviral vectors for transducing β-globin gene and β-locus control region derivativesMASSACHUSETTS INST TECHNOLOGY·Filed 1993·Granted May 20, 1997·7 cites·38 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →